Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Diabetes Reports
Erschienen in: Current Diabetes Reports 7/2017

01.07.2017 | Psychosocial Aspects (S Jaser, Section Editor)

Psychosocial Patient-Reported Outcomes in Pediatric and Adolescent Diabetes: a Review and Case Example

verfasst von: Sarah D. Corathers, Constance A. Mara, Pavan K. Chundi, Jessica C. Kichler

Erschienen in: Current Diabetes Reports | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The purpose of this review is to define psychosocial patient-reported outcomes (PROs) relevant to pediatric and adolescent diabetes populations. Potential domains for PROs include a spectrum of emotional, behavioral, social, physical, overall health, and/or care management areas. A literature review of potential PRO measures, selection criteria, and implementation strategies including a case example will be presented.

Recent Findings

Among the pediatric, adolescent, and emerging adult populations, research indicates a relative higher risk for distress, depression, anxiety, and eating disorders as compared to peers without diabetes. Use of PRO measures can expand providers’ focus beyond glycemic control, or simply hemoglobin A1c, to better appreciate the impact of diabetes on the whole child/adolescent, and provide services that address patients’ individually identified needs, which are most salient to them.

Summary

Successful selection and implementation of psychosocial PRO measures should be designed to include pathways for real-time provider interaction with the patient and respective PRO data to guide clinical care.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Liese AD, D'Agostino Jr RB, Hamman RF, Kilgo PD, Lawrence JM, et al. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for diabetes in youth study. Pediatrics. 2006;118(4):1510–8.CrossRefPubMed
2.
Modi AC, Pai AL, Hommel KA, Hood KK, Cortina S, Hilliard ME, et al. Pediatric self-management: a framework for research, practice, and policy. Pediatrics. 2012;129(2):e473–85.CrossRefPubMed
3.
Garvey KC, Foster NC, Agarwal S, DiMeglio LA, Anderson BJ, Corathers SD, et al. Health care transition preparation and experiences in a U.S. National Sample of Young Adults With Type 1 Diabetes. Diabetes Care. 2016.
4.
Chiang JL, Kirkman MS, Laffel LM, Peters AL. Type 1 diabetes sourcebook A. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care. 2014;37(7):2034–54.CrossRefPubMed
5.
Wood JR, Miller KM, Maahs DM, Beck RW, DiMeglio LA, Libman IM, et al. Most youth with type 1 diabetes in the T1D exchange clinic registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care. 2013;36(7):2035–7.CrossRefPubMedPubMedCentral
6.
Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M. Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(12):2126–40.CrossRefPubMed
7.
Iturralde E, Weissberg-Benchell J, Hood KK. Avoidant coping and diabetes-related distress: pathways to adolescents' type 1 diabetes outcomes. Health Psychol. 2016.
8.
Lohr KN, Zebrack BJ. Using patient-reported outcomes in clinical practice: challenges and opportunities. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2009;18(1):99–107.CrossRef
9.
10.
• Pyatak EA, Sequeira PA, Vigen CL, Weigensberg MJ, Wood JR, Montoya L, et al. Clinical and psychosocial outcomes of a structured transition program among young adults with type 1 diabetes. J Adolesc Health. 2017;60(2):212–8. Study of a structured transition program intervention that includes clinical, health utilization and psychosocial outcomes to evaluate effectiveness. CrossRefPubMed
11.
Rodbard HW, Peters AL, Slee A, Cao A, Traina SB, Alba M. The effect of canagliflozin, a sodium glucose cotransporter 2 inhibitor, on glycemic end points assessed by continuous glucose monitoring and patient-reported outcomes among people with type 1 diabetes. Diabetes Care. 2017;40(2):171–80.CrossRefPubMed
12.
Tanenbaum ML, Hanes SJ, Miller KM, Naranjo D, Bensen R, Hood KK. Diabetes device use in adults with type 1 diabetes: barriers to uptake and potential intervention targets. Diabetes Care. 2017;40(2):181–7.CrossRefPubMed
13.
• Weissberg-Benchell J, Hood K, Laffel L, Heinemann L, Ball D, Kowalski A, et al. Toward development of psychosocial measures for automated insulin delivery. J Diabetes Sci Technol. 2016;10(3):799–801. This paper highlights the need for new psychosocial outcome measures to address the patient experience for emerging diabetes technologies including automated insulin delivery systems in order to evaluate both physiologic and psychologic metics of treatment interventions. CrossRefPubMed
14.
Sharifi A, De Bock MI, Jayawardene D, Loh MM, Horsburgh JC, Berthold CL, et al. Glycemia, treatment satisfaction, cognition, and sleep quality in adults and adolescents with type 1 diabetes when using a closed-loop system overnight versus sensor-augmented pump with low-glucose suspend function: a randomized crossover study. Diabetes Technol Ther. 2016;18(12):772–83.CrossRefPubMed
15.
Standards of Medical Care in Diabetes. Summary of revisions. Diabetes Care. 2017;40(Suppl 1):S4–5.
16.
Delamater AM, de Wit M, McDarby V, Malik J, Acerini CL, International Society for P, et al. ISPAD clinical practice consensus guidelines 2014. Psychological care of children and adolescents with type 1 diabetes. Pediatr Diabetes. 2014;15(Suppl 20):232–44.CrossRefPubMed
17.
Peters A, Laffel L, Transitions ADA. Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems. Diabetes Care. 2011;34(11):2477–85.CrossRefPubMedPubMedCentral
18.
Langley GJ. The improvement guide: a practical approach to enhancing organizational performance. 2nd ed. San Francisco: Jossey-Bass; 2009. xxi, 490 p. p.
19.
Forrest CB, Bevans KB, Pratiwadi R, Moon J, Teneralli RE, Minton JM, et al. Development of the PROMIS (R) pediatric global health (PGH-7) measure. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2014;23(4):1221–31.CrossRef
20.
Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, et al. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005;28(3):626–31.CrossRefPubMed
21.
Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18(6):754–60.CrossRefPubMed
22.
Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care. 1987;10(5):617–21.CrossRefPubMed
23.
Kamps JL, Roberts MC, Varela RE. Development of a new fear of hypoglycemia scale: preliminary results. J Pediatr Psychol. 2005;30(3):287–91.CrossRefPubMed
24.
Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39(8):800–12.CrossRefPubMed
25.
Green LB, Wysocki T, Reineck BM. Fear of hypoglycemia in children and adolescents with diabetes. J Pediatr Psychol. 1990;15(5):633–41.CrossRefPubMed
26.
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.CrossRefPubMed
27.
28.
La Greca AM, Bearman KJ. The diabetes social support questionnaire-family version: evaluating adolescents' diabetes-specific support from family members. J Pediatr Psychol. 2002;27(8):665–76.CrossRefPubMed
29.
Procidano ME, Heller K. Measures of perceived social support from friends and from family: three validation studies. Am J Community Psychol. 1983;11(1):1–24.CrossRefPubMed
30.
Schmitt A, Gahr A, Hermanns N, Kulzer B, Huber J, Haak T. The diabetes self-management questionnaire (DSMQ): development and evaluation of an instrument to assess diabetes self-care activities associated with glycaemic control. Health Qual Life Outcomes. 2013;11:138.CrossRefPubMedPubMedCentral
31.
Schafer LC, McCaul KD, Glasgow RE. Supportive and nonsupportive family behaviors: relationships to adherence and metabolic control in persons with type I diabetes. Diabetes Care. 1986;9(2):179–85.CrossRefPubMed
32.
Melamed S, Kushnir T, Shirom A. Burnout and risk factors for cardiovascular diseases. Behav Med. 1992;18(2):53–60.CrossRefPubMed
33.
Rubin RR, Peyrot M, Saudek CD. Effect of diabetes education on self-care, metabolic control, and emotional well-being. Diabetes Care. 1989;12(10):673–9.CrossRefPubMed
34.
Streisand R, Braniecki S, Tercyak KP, Kazak AE. Childhood illness-related parenting stress: the pediatric inventory for parents. J Pediatr Psychol. 2001;26(3):155–62.CrossRefPubMed
35.
Varni JW, Sherman SA, Burwinkle TM, Dickinson PE, Dixon P. The PedsQL Family Impact Module: preliminary reliability and validity. Health Qual Life Outcomes. 2004;2:55.CrossRefPubMedPubMedCentral
36.
Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23(7):943–50.CrossRefPubMed
37.
Brownlee-Duffeck M, Peterson L, Simonds JF, Goldstein D, Kilo C, Hoette S. The role of health beliefs in the regimen adherence and metabolic control of adolescents and adults with diabetes mellitus. J Consult Clin Psychol. 1987;55(2):139–44.CrossRefPubMed
38.
Tran VT, Harrington M, Montori VM, Barnes C, Wicks P, Ravaud P. Adaptation and validation of the Treatment Burden Questionnaire (TBQ) in English using an internet platform. BMC Med. 2014;12:109.CrossRefPubMedPubMedCentral
39.
Van Der Ven NC, Weinger K, Yi J, Pouwer F, Ader H, Van Der Ploeg HM, et al. The confidence in diabetes self-care scale: psychometric properties of a new measure of diabetes-specific self-efficacy in Dutch and US patients with type 1 diabetes. Diabetes Care. 2003;26(3):713–8.CrossRefPubMedPubMedCentral
40.
41.
Welch GW, Jacobson AM, Polonsky WH. The problem areas in diabetes scale. An evaluation of its clinical utility. Diabetes Care. 1997;20(5):760–6.CrossRefPubMed
42.
Mulvaney SA, Hood KK, Schlundt DG, Osborn CY, Johnson KB, Rothman RL, et al. Development and initial validation of the barriers to diabetes adherence measure for adolescents. Diabetes Res Clin Pract. 2011;94(1):77–83.CrossRefPubMedPubMedCentral
43.
Owens JA, Spirito A, McGuinn M. The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. Sleep. 2000;23(8):1043–51.CrossRefPubMed
44.
Owens JA, Maxim R, Nobile C, McGuinn M, Msall M. Parental and self-report of sleep in children with attention-deficit/hyperactivity disorder. Archives of pediatrics & adolescent medicine. 2000;154(6):549–55.CrossRef
45.
Markowitz JT, Butler DA, Volkening LK, Antisdel JE, Anderson BJ, Laffel LM. Brief screening tool for disordered eating in diabetes: internal consistency and external validity in a contemporary sample of pediatric patients with type 1 diabetes. Diabetes Care. 2010;33(3):495–500.CrossRefPubMed
46.
Rose M, Bezjak A. Logistics of collecting patient-reported outcomes (PROs) in clinical practice: an overview and practical examples. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2009;18(1):125–36.CrossRef
47.
Almario CV, Chey WD, Khanna D, Mosadeghi S, Ahmed S, Afghani E, et al. Impact of National Institutes of Health Gastrointestinal PROMIS measures in clinical practice: results of a multicenter controlled trial. Am J Gastroenterol. 2016;111(11):1546–56.CrossRefPubMedPubMedCentral
48.
Greenhalgh J, Long AF, Flynn R. The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? Soc Sci Med. 2005;60(4):833–43.CrossRefPubMed
49.
de Wit M, Delemarre-van de Waal HA, Bokma JA, Haasnoot K, Houdijk MC, Gemke RJ, et al. Monitoring and discussing health-related quality of life in adolescents with type 1 diabetes improve psychosocial well-being: a randomized controlled trial. Diabetes Care. 2008;31(8):1521–6.CrossRefPubMedPubMedCentral
50.
de Wit M, Delemarre-van de Waal HA, Bokma JA, Haasnoot K, Houdijk MC, Gemke RJ, et al. Follow-up results on monitoring and discussing health-related quality of life in adolescent diabetes care: benefits do not sustain in routine practice. Pediatr Diabetes. 2010;11(3):175–81.CrossRefPubMed
51.
Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, et al. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation. 2012;21(8):1305–14.CrossRef
52.
Corathers SD, Kichler J, Jones NH, Houchen A, Jolly M, Morwessel N, et al. Improving depression screening for adolescents with type 1 diabetes. Pediatrics. 2013;132(5):e1395–402.CrossRefPubMed
53.
Kovacs M, Staff M. Children’s Depression Inventory (CDI): technical manual update. Multi-Health Systemc. Inc: North Tonawanda; 2003.
54.
Allgaier A-K, Frühe B, Pietsch K, Saravo B, Baethmann M, Schulte-Körne G. Is the Children's Depression Inventory Short version a valid screening tool in pediatric care? A comparison to its full-length version. J Psychosom Res. 2012;73(5):369–74.CrossRefPubMed
55.
Varni JW, Seid M, Kurtin PS. PedsQL™ 4.0: reliability and validity of the Pediatric Quality of Life Inventory™ Version 4.0 Generic Core Scales in healthy and patient populations. Med Care. 2001;39(8):800–12.CrossRefPubMed
56.
Varni JW, Bendo CB, Shulman RJ, Self MM, Nurko S, Franciosi JP, et al. Interpretability of the PedsQL gastrointestinal symptoms scales and gastrointestinal worry scales in pediatric patients with functional and organic gastrointestinal diseases. J Pediatr Psychol. 2015;40(6):591–601.CrossRefPubMedPubMedCentral
57.
Varni JW, Curtis BH, Abetz LN, Lasch KE, Piault EC, Zeytoonjian AA. Content validity of the PedsQL 3.2 Diabetes Module in newly diagnosed patients with type 1 diabetes mellitus ages 8–45. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2013;22(8):2169–81.CrossRef
58.
Hilliard ME, Lawrence JM, Modi AC, Anderson A, Crume T, Dolan LM, et al. Identification of minimal clinically important difference scores of the PedsQL in children, adolescents, and young adults with type 1 and type 2 diabetes. Diabetes Care. 2013;36(7):1891–7.CrossRefPubMedPubMedCentral
59.
Hilliard ME, Herzer M, Dolan LM, Hood KK. Psychological screening in adolescents with type 1 diabetes predicts outcomes one year later. Diabetes Res Clin Pract. 2011;94(1):39–44.CrossRefPubMedPubMedCentral
60.
• Santana MJ, Haverman L, Absolom K, Takeuchi E, Feeny D, Grootenhuis M, et al. Training clinicians in how to use patient-reported outcome measures in routine clinical practice. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation. 2015;24(7):1707–18. The authors explore 3 different implementation strategies for adult learning of how to train clinicians to react to patient reported data. These variable settings create a framework for a more generalizable application of use of PRO measures in practice. CrossRef
Metadaten
Titel
Psychosocial Patient-Reported Outcomes in Pediatric and Adolescent Diabetes: a Review and Case Example
verfasst von
Sarah D. Corathers
Constance A. Mara
Pavan K. Chundi
Jessica C. Kichler
Publikationsdatum
01.07.2017
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 7/2017
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-017-0872-5

Weitere Artikel der Ausgabe 7/2017

Current Diabetes Reports 7/2017 Zur Ausgabe

Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (B Conway and H Keenan, Section Editors)

Microvascular Complications Associated With Rapid Improvements in Glycemic Control in Diabetes

Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors)

SGLT2-I in the Hospital Setting: Diabetic Ketoacidosis and Other Benefits and Concerns

Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors)

Practical Recommendations for Transitioning Patients with Type 2 Diabetes from Hospital to Home

Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors)

The Case for Diabetes Population Health Improvement: Evidence-Based Programming for Population Outcomes in Diabetes

Psychosocial Aspects (S Jaser, Section Editor)

Assessing Psychological Insulin Resistance in Type 2 Diabetes: a Critical Comparison of Measures

Immunology, Transplantation, and Regenerative Medicine (L Piemonti and V Sordi, Section Editors)

Islet Microencapsulation: Strategies and Clinical Status in Diabetes

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

CKD bei Diabetes: Neuheiten und Zukunftsaussichten

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Jeder Mensch mit Diabetes muss auf eine chronische Nierenerkrankung gescreent werden – diese neue Empfehlung spricht die KDIGO aus. Die Therapie erfolgt individuell und je nach Szenario mit verschiedenen Substanzklassen. Künftig kommt wahrscheinlich, neben RAS-Hemmung, SGLT2-Inhibition und nsMRA, eine vierte Therapiesäule hinzu.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise